If approved, Pfizer’s sasanlimab will distinguish itself from Merck’s blockbuster Keytruda as the first PD-1 inhibitor ...

Seasoned advisory group including RNA, translation and commercialisation luminaries.

EQS-AFR: Merck KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

So they teamed up with Cornell nanoscientist Paul McEuen to create wireless light-powered microelectronic devices that can turn nearly any well plate into an array of teeny-tiny electrochemical ...

Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a ...

M-Trust – which is now in beta test release mode – is described by the company as a "cyber-physical trust platform." ...

China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

Merck's Winrevair (sotatercept) gains UK approval for PAH treatment. Key trial results highlight significant exercise ...

Explore some of the top Dow Jones laggards like Nike, Boeing, and Amgen and why they may become the top gainers in 2025 ...